MAPT and red-green color blindness: The third pattern (Fig. 2d) is exemplified by CBD, where subpial tau immunoreactivity of astrocytic end-feet in lobar areas is the predominant pathology independently of subpial ARTAG in basal brain regions (together representing stage 1) and both are followed by the involvement of the brainstem, representing stage 2.